Cardiorenalmetabolic

Latest News

Anjali Vaidya, MD, FACC, FASE, FACP | Image Credit: Temple University Hospital
Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD

September 17th 2025

New findings reveal sotatercept's significant benefits for right ventricular function and tricuspid regurgitation in pulmonary arterial hypertension.

Diabetes monitoring | Image credit: andre - stock.adobe.com
Assessing the Rising Prevalence of Early-Onset Type 2 Diabetes in the US

September 16th 2025

Scottsdale Arizona | Image Credit: © tim - stock.adobe.com
Team Coordination, Data Sharing Help Prioritize Value in Cardio-Renal-Metabolic Care

September 12th 2025

Aurora Colorado aerial | Image Credit: © Jacob - stock.adobe.com
Mitigating Cardiometabolic Risk Through Therapies, Weight Management

September 12th 2025

Women holding up heart hands | Image credit: Studio Romantic – stock.adobe.com
Women Still Underrepresented in Key Cardiovascular Trials

September 11th 2025

More News

GLP-1 | Image Credit: © designua-stock.adobe.com
January 6th 2025

Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety

Maggie L. Shaw
For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL from inception through October 4, 2024.
Dr Yehuda Handelsman
January 3rd 2025

Dr Yehuda Handelsman: DCRM Guidelines Are Shaping Integrated, Global CRM Care

Brooke McCormick
In part 2 of our interview, Yehuda Handelsman, MD, discusses how cardiorenalmetabolic (CRM) disease management is advancing with the 2022 Diabetes, Cardiorenal, and Metabolic (DCRM) multispecialty practice recommendations and the updated DCRM 2.0 guidelines.
AJMC Q&A with Ian Neeland, MD | Background image credit: ipopba - stock.adobe.com
January 1st 2025

Overcoming Barriers to Guideline-Directed Cardiometabolic Care

Hayden E. Klein
According to Ian Neeland, MD, strategies like pharmacist-led counseling, patient education programs, and patient assistance initiatives are key to addressing therapeutic inertia.
the top 5 heart failure content of 2024
December 23rd 2024

Top 5 Most-Read Heart Failure Articles of 2024

Hayden E. Klein
Some of the top heart failure research looked at statins and semaglutide for heart failure with preserved ejection fraction, diabetes-related heart failure risks, and the protective cardiovascular effects of COVID-19 vaccination.
FDA website | Image credit: Postmodern Studio – stock.adobe.com
December 20th 2024

FDA Rejects Sotagliflozin for Type 1 Diabetes; Lexicon Shifts Focus

Hayden E. Klein
The FDA issued a complete response letter for sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control.
AJMC Q&A with Ian Neeland, MD | Background image credit: ipopba - stock.adobe.com
December 20th 2024

Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes

Hayden E. Klein
Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.
Dr Yehuda Handelsman
December 20th 2024

Dr Yehuda Handelsman on How DCRM 2.0 Guidelines Refine CRM Disease Management

Brooke McCormick
In this interview, Yehuda Handelsman, MD, highlights key updates to the Diabetes, Cardiorenal, and Metabolic (DCRM) guidelines in DCRM 2.0, shaped by global collaboration and recent clinical insights.
Top 5 conference coverage of 2024
December 17th 2024

Top 5 Conference Coverage of 2024

Hayden E. Klein
Health care conferences this year showcased advancements in treatments for chronic obstructive pulmonary disease and sleep apnea, discussions around health policy and economic research, and more.
AJMC Q&A with Ellen Francis, PhD | Background image credit: ipopba - stock.adobe.com
December 17th 2024

Early Diabetes Screening in Pregnancy: Challenges and Opportunities

Hayden E. Klein
Ellen Francis, PhD, discusses the benefits, challenges, and future implications of implementing earlier diabetes screening for pregnant women.
Ozempic for diabetes | Image credit: mbruxelle – stock.adobe.com
December 17th 2024

Semaglutide Linked to Increased Risk of Rare, Debilitating Eye Condition

Hayden E. Klein
Patients with type 2 diabetes who use semaglutide have more than double the risk of severe optic nerve damage than those who don’t use the drug.
The top 5 diabetes content of 2024
December 16th 2024

Top 5 Most-Viewed Diabetes Content of 2024

Hayden E. Klein
This year’s top diabetes content focused on pediatric metabolic health, misconceptions about weight loss drugs, and more.
Highlights From ESC Congress 2024
December 12th 2024

ICYMI: Highlights From ESC Congress 2024

Hayden E. Klein
Top coverage from the 2024 European Society of Cardiology (ESC) Congress focused on screening, treatment, and equity in cardiovascular care.
Tirzepatide box sold as Mounjaro | Image credit: Cynthia – stock.adobe.com
December 5th 2024

How Tirzepatide Benefits Patients With Obesity-Related HFpEF

Hayden E. Klein
A SUMMIT trial analysis showed how tirzepatide improves cardiovascular and kidney health in patients with obesity-related heart failure with preserved ejection fraction (HFpEF).
Cardiovascular health | Image Credit: BillionPhotos.com - stock.adobe.com
November 25th 2024

Unfavorable Health-Related Social Needs Associated With Lower Cardiovascular Health Scores

Brooke McCormick
Adults with more unfavorable health-related social needs, such as unemployment or food insecurity, had a higher prevalence of low cardiovascular health, highlighting the importance of addressing social determinants to improve population health.
Doctor measuring patient's blood pressure | Image credit: Andrey Popov – stock.adobe.com
November 19th 2024

Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes

Connor Iapoce
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Doctor writing prescription | Image credit: 18percentgrey – stock.adobe.com
November 18th 2024

SGLT2i Prescriptions for Heart Failure Are Rising, but Vary Across US

Hayden E. Klein
Of the 518 hospitals that had at least 10 eligible discharges, only 11 of them prescribed SGLT2 inhibitors to more than half of their patients.
Masanori Aikawa, MD
November 18th 2024

Innovations in Atherosclerosis Have Potential to Benefit Patients With CKD, HIV

Kyle Munz
New discoveries in atherosclerosis pathways have shed light on the active mechanisms in other diseases such as chronic kidney disease (CKD) and HIV, paving the way for furture therapeutics.
AJMC Q&A with Dr Sanjula Jain | Background image credit: ipopba – stock.adobe.com
November 5th 2024

Rethinking Diabetes Care: Are New Therapies Adding Value or Cost?

Hayden E. Klein
Sanjula Jain, PhD, chief research officer at Trilliant Health, discusses the rapid adoption of glucagon-like peptide 1 inhibitors for diabetes and preventive care for obesity and late-onset diabetes.
Doctor holding stethoscope to red heart | Image credit: lenets_tan – stock.adobe.com
October 18th 2024

How the Clinical Trial Gender Gap Affects Women’s Heart Care

Hayden E. Klein
The history of women being left out of heart disease research has had significant consequences on heart health care today.
Navdeep Tangri, MD, PhD, FRCP
October 18th 2024

Population Health Strategies Are Vital for Tackling, Improving CKD Care

Kyle Munz
Navdeep Tangri, MD, PhD, FRCP, University of Manitoba, speaks to the value of population health strategies in clinical approaches to care delivery for patients with chronic kidney disease (CKD).
Aerial shot of neighborhood | Image credit: trekandphoto – stock.adobe.com
October 18th 2024

How Neighborhood Social Needs Drive Diabetes Care Disparities

Hayden E. Klein
Unmet social needs in certain neighborhoods contribute to disparities in diabetes care, leading to greater reliance on emergency services, fewer preventive measures, and higher rates of complications.
Woman at heart doctor | Image credit: Seventyfour – stock.adobe.com
October 15th 2024

Why Are We Still Seeing Gaps in Women’s Heart Care?

Hayden E. Klein
Women are still being excluded from cardiovascular research trials, and it has a lasting impact on heart disease treatment for women today.
Blood pressure monitor | Image credit: Photo Sesaon – stock.adobe.com
October 11th 2024

Remote Monitoring Program Cuts Heart Failure Readmissions in Half

Hayden E. Klein
UMass Memorial Health–Harrington Hospital reduced 30-day readmissions for congestive heart failure by 50% using artificial intelligence and remote care teams.
AJMC
October 10th 2024

Impact of Functional Recovery on Patients Having Heart Surgery

Richard J. Snow, DO, MPH Lauren McKown, JD, MPH Geoffrey Blossom, MD Karen Vogel, MPA Amy Creighton, MS Jason Shriver, OT Linda Will, APN Katie Lentz, PT, DPT Elizabeth Snow, MPH Teresa Caulin-Glaser, MD
This article describes the positive impact that actively managing functional recovery has on postacute placement for patients undergoing coronary artery bypass surgery.
Heart and stethoscope | Image credit: New Africa – stock.adobe.com
October 2nd 2024

Optimizing GDMT Could Prevent Over 1 Million HFrEF Deaths Annually

Hayden E. Klein
Despite being eligible for guideline-directed medical therapy (GDMT), tens of millions of patients across the globe are not receiving the heart failure care they need.
Diabetes | Image credit: Sherry Young – stock.adobe.com
October 1st 2024

What the Diabetes Health Economy Looks Like in 2024

Hayden E. Klein
The 2024 Trends Shaping the Health Economy report gave a past, present, and future look at diabetes care in the US and the role of obesity in these trends.
National Cholesterol Education month | Image Credit: © Waseem Ali Khan-stock.adobe.com
September 30th 2024

At-Home Cholesterol Screening Accessible Through New Program

Maggie L. Shaw
The innovative program from the Family Heart Foundation includes being able to order a free test kit for an at-home blood lipid panel and track your results online, as well as the ability to discuss the findings with care navigators and health care providers.
Heart failure | Image credit: irissca – stock.adobe.com
September 26th 2024

Adherence to 2021 ESC Heart Failure Guidelines Differed Across Practices

Hayden E. Klein
Inconsistent adherence to the guidelines led to delayed heart failure treatment optimization and underutilization of key therapies.
Hospital sign | Image credit: merrimonc – stock.adobe.com
September 25th 2024

Study Reveals High Variability in Hospital GDMT Scores, Outcomes, Costs

Hayden E. Klein
Hospitals that better utilized heart failure guideline-directed medical therapy (GDMT) had better patient outcomes, with lower mortality rates and costs.
DNA double helix | Image credit: Dr_Microbe – stock.adobe.com
September 24th 2024

The Role of Genetics in Cholesterol, Heart Disease Risk

Hayden E. Klein
A collection of research by Helen Hobbs, MD, highlights how genetic mutations influence cholesterol levels and impact heart disease risk, offering insights into lifelong cardiovascular health management.
<123456>

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo